AU8555198A - 5' ests for secreted proteins expressed in prostate - Google Patents

5' ests for secreted proteins expressed in prostate Download PDF

Info

Publication number
AU8555198A
AU8555198A AU85551/98A AU8555198A AU8555198A AU 8555198 A AU8555198 A AU 8555198A AU 85551/98 A AU85551/98 A AU 85551/98A AU 8555198 A AU8555198 A AU 8555198A AU 8555198 A AU8555198 A AU 8555198A
Authority
AU
Australia
Prior art keywords
sequences
cdna
seq
protein
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85551/98A
Other languages
English (en)
Inventor
Aymeric Duclert
Jean-Baptiste Dumas Milne Edwards
Bruno Lacroix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Publication of AU8555198A publication Critical patent/AU8555198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU85551/98A 1997-08-01 1998-07-31 5' ests for secreted proteins expressed in prostate Abandoned AU8555198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90514497A 1997-08-01 1997-08-01
US08905144 1997-08-01
PCT/IB1998/001232 WO1999006550A2 (fr) 1997-08-01 1998-07-31 Marqueurs sequences 5' exprimes pour proteines secretees exprimees dans la prostate

Publications (1)

Publication Number Publication Date
AU8555198A true AU8555198A (en) 1999-02-22

Family

ID=25420349

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85551/98A Abandoned AU8555198A (en) 1997-08-01 1998-07-31 5' ests for secreted proteins expressed in prostate

Country Status (5)

Country Link
EP (1) EP1000148A2 (fr)
JP (1) JP2001512013A (fr)
AU (1) AU8555198A (fr)
CA (1) CA2296287A1 (fr)
WO (1) WO1999006550A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003262114B2 (en) * 1998-02-09 2006-07-13 Serono Genetics Institute S.A. cDNAs encoding secreted proteins

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6656480B2 (en) * 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6613872B1 (en) 1997-02-25 2003-09-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
CA2281952C (fr) 1997-02-25 2011-07-19 Corixa Corporation Composes permettant l'immunotherapie du cancer de la prostate et procedes concernant leur utilisation
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6261562B1 (en) 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20030054359A1 (en) 1997-06-16 2003-03-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
WO1999040189A2 (fr) * 1998-02-09 1999-08-12 Genset ADNc CODANT DES PROTEINES SECRETEES
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6365369B1 (en) 1998-04-01 2002-04-02 Human Genome Sciences, Inc. Prostate specific secreted protein
GB9807723D0 (en) * 1998-04-08 1998-06-10 Smithkline Beecham Plc Novel compounds
DE19818620A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Normal
US20030036114A1 (en) 1998-05-15 2003-02-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999060121A1 (fr) * 1998-05-19 1999-11-25 Compugen Ltd. PROTEINE DU TYPE RECEPTEUR DE GLUTAMATE METABOTROPIQUE ET ADNc DE CODAGE
US20060052321A1 (en) 2002-04-05 2006-03-09 Raitano Arthur B Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US20040141975A1 (en) 1998-06-01 2004-07-22 Raitano Arthur B. Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
EP1086223B1 (fr) 1998-06-01 2009-07-29 Agensys, Inc. Nouveaux antigenes transmembranaires du type serpentin exprimes dans des cancers humains et utilisation de ces antigenes
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
AU761340B2 (en) * 1998-06-02 2003-06-05 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
WO2000014226A1 (fr) * 1998-09-03 2000-03-16 Takeda Chemical Industries, Ltd. Nouvelle proteine et son procede de production
WO2000015793A2 (fr) * 1998-09-17 2000-03-23 Incyte Pharmaceuticals, Inc. Proteines gpcr humaines
ATE364628T1 (de) * 1999-03-08 2007-07-15 Genentech Inc Verfahren und zusammensetzungen zur diagnose von tumoren
EP1169442B1 (fr) 1999-03-23 2006-06-07 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
EP1792989A1 (fr) * 1999-04-12 2007-06-06 Agensys, Inc. Protéine à treize segments transmembranaires exprimée dans le cancer de la prostate
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
IL145775A0 (en) * 1999-04-12 2002-07-25 Agensys Inc 13 transmembrane protein expressed in prostate cancer
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
AU3246100A (en) * 1999-06-02 2000-12-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
ATE478145T1 (de) * 1999-06-02 2010-09-15 Genentech Inc Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
CA2383828A1 (fr) * 1999-06-07 2000-12-14 Human Genome Sciences, Inc. 26 proteines humaines secretees
US20030022279A1 (en) 1999-06-14 2003-01-30 Fraser Christopher C. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
US7033780B1 (en) 1999-06-14 2006-04-25 Millennium Pharmaceuticals, Inc. Nucleic acids corresponding to TANGO 294 a gene encoding a lipase—like protein
EP1194545A2 (fr) * 1999-06-23 2002-04-10 Curagen Corporation Polypeptides secretes et polynucleotides correspondants
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
CA2381327A1 (fr) * 1999-07-16 2001-01-25 Steven M. Ruben Recepteurs du facteur de necrose des tumeurs humain tr13 et tr14
CA2381396A1 (fr) * 1999-08-11 2001-02-15 Curagen Corporation Polynucleotides et polypeptides codes par ces derniers
WO2001019856A2 (fr) * 1999-09-13 2001-03-22 Curagen Corporation Nouvelles proteines humaines, polynucleotides codant celles-ci et procedes d'utilisation des memes
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
ES2316387T3 (es) * 1999-10-05 2009-04-16 Agensys, Inc. Receptor acoplado a proteina g sobrexpresado en cancer de prostata y la utilizacion del mismo.
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
US7208280B2 (en) 1999-10-05 2007-04-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US6835822B1 (en) 1999-10-28 2004-12-28 Agensys, Inc. Diagnosis and therapy of cancer using SGP28-related molecules
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
EP1598671A1 (fr) * 1999-10-28 2005-11-23 Agensys, Inc. Diagnotic et traitement du cancer par des molecules apparentées à SGP28
FR2800388A1 (fr) * 1999-10-29 2001-05-04 Pf Medicament Clonage, expression et caracterisation d'un gene exprime dans des cellules tumorales et implique dans la regulation de la reponse immune
WO2001036465A2 (fr) * 1999-11-16 2001-05-25 Zymogenetics, Inc. Proteines humaines zven
US6485938B1 (en) 1999-11-16 2002-11-26 Zymogenetics, Inc. Nucleic acid molecules that encodes human Zven1
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
US20020037513A1 (en) * 2000-03-24 2002-03-28 Rosana Kapeller-Libermann 33338, a novel human ubiquitin hydrolase-like molecule and uses thereof
KR100904593B1 (ko) * 2000-06-23 2009-06-25 제넨테크, 인크. Ｅｇ-ｖｅｇｆ 핵산 및 폴리펩티드 및 사용 방법
EP1302542B1 (fr) 2000-07-18 2007-06-13 Takeda Pharmaceutical Company Limited Nouveau peptide actif sur le plan physiologique et utilisation associee
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2002062996A1 (fr) * 2001-02-02 2002-08-15 Takeda Chemical Industries, Ltd. Nouveau peptide physiologiquement actif et utilisation de ce peptide
AUPR311601A0 (en) * 2001-02-15 2001-03-08 Adp Pharmaceutical Pty Limited Matrix gene expression in chondrogenesis
US7070584B2 (en) 2001-02-20 2006-07-04 Kci Licensing, Inc. Biocompatible wound dressing
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
AU2002318112B2 (en) 2001-04-10 2007-12-06 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
ES2532757T3 (es) 2001-09-06 2015-03-31 Agensys, Inc. Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
AU2003295343A1 (en) 2002-10-07 2004-04-23 Zymogenetics, Inc. Uses of human zven proteins and polynucleotides
EP1565200A4 (fr) * 2002-11-27 2009-06-24 Agensys Inc Acide nucleique 24p4c12 et proteine correspondante utilises dans le traitement et la detection du cancer
KR101118340B1 (ko) 2003-03-12 2012-04-12 제넨테크, 인크. 조혈을 촉진하기 위한 ｂｖ８ 및(또는) ｅｇ-ｖｅｇｆ의용도
PL1742966T3 (pl) 2004-04-22 2014-04-30 Agensys Inc Przeciwciała i pochodzące z nich cząsteczki, które wiążą się z białkami STEAP-1
FR2982860B1 (fr) * 2011-11-18 2015-07-10 Ass Fr Contre Les Myopathies Utilisation de la fibromoduline et du lumican pour augmenter la masse musculaire
GB201511792D0 (en) * 2015-07-06 2015-08-19 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
EA201792671A1 (ru) 2015-07-06 2018-06-29 Имматикс Байотекнолоджиз Гмбх Новые пептиды и комбинации пептидов для применения в иммунотерапии рака пищевода и других видов рака
SG11201909218RA (en) 2017-04-03 2019-11-28 Hoffmann La Roche Antibodies binding to steap-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0832981A1 (fr) * 1987-02-17 1998-04-01 Pharming B.V. Séquences d'ADN pour diriger des protéines vers les glandes mammaires, afin d'être secrétées efficacement
JP3337748B2 (ja) * 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法
FR2733762B1 (fr) * 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003262114B2 (en) * 1998-02-09 2006-07-13 Serono Genetics Institute S.A. cDNAs encoding secreted proteins
AU2003262114B8 (en) * 1998-02-09 2006-08-03 Serono Genetics Institute S.A. cDNAs encoding secreted proteins

Also Published As

Publication number Publication date
WO1999006550A2 (fr) 1999-02-11
WO1999006550A3 (fr) 1999-04-29
CA2296287A1 (fr) 1999-02-11
JP2001512013A (ja) 2001-08-21
WO1999006550B1 (fr) 1999-06-03
EP1000148A2 (fr) 2000-05-17

Similar Documents

Publication Publication Date Title
EP1000146B1 (fr) Est 5' pour proteines secretees sans specificite tissulaire
EP1000150B1 (fr) Est 5' pour proteines secretees exprimees dans le cerveau
EP1378571B1 (fr) EST 5' pour proteines sécretées exprimées dans divers tissues
EP1037977B1 (fr) ADNc PROLONGES POUR PROTEINES SECRETEES
US6936692B2 (en) Complementary DNAs
EP1367124A1 (fr) Est 5' pour protéines secrétées, exprimées dans des tissus musculaires et autres tissus mésodermiques
AU8555198A (en) 5' ests for secreted proteins expressed in prostate
EP1000149B1 (fr) Est 5' pour proteines secretees identifiees dans le tissu cerebral
EP1000151B1 (fr) Est 5' pour proteines secretees exprimees dans divers tissus
AU8555298A (en) 5' ests for secreted proteins expressed in endoderm
AU2006201603B2 (en) Extended cDNAs for secreted proteins
AU2003262114B8 (en) cDNAs encoding secreted proteins
AU2006225329A1 (en) cDNAs encoding secreted proteins

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted